X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8853) 8853
Publication (953) 953
Book Review (197) 197
Book Chapter (128) 128
Conference Proceeding (18) 18
Book / eBook (14) 14
Dissertation (4) 4
Data Set (2) 2
Presentation (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6133) 6133
index medicus (4849) 4849
oncology (4383) 4383
cancer (3175) 3175
female (2770) 2770
male (2424) 2424
middle aged (2230) 2230
aged (2046) 2046
metastasis (1956) 1956
metastatic melanoma (1801) 1801
chemotherapy (1717) 1717
adult (1625) 1625
care and treatment (1567) 1567
immunotherapy (1509) 1509
animals (1380) 1380
tumors (1239) 1239
treatment outcome (1220) 1220
metastatic colorectal-cancer (1209) 1209
medicine & public health (1101) 1101
antineoplastic agents - therapeutic use (1055) 1055
research (1043) 1043
pharmacology & pharmacy (951) 951
melanoma (941) 941
metastatic breast-cancer (886) 886
neoplasms - drug therapy (881) 881
survival (872) 872
antineoplastic combined chemotherapy protocols - therapeutic use (865) 865
health aspects (826) 826
immunology (820) 820
metastatic renal cell carcinoma (800) 800
renal-cell carcinoma (799) 799
prognosis (778) 778
aged, 80 and over (773) 773
neoplasm metastasis (767) 767
therapy (738) 738
analysis (715) 715
drug therapy (711) 711
cell lung-cancer (670) 670
clinical trials (663) 663
phase-ii trial (651) 651
surgery (647) 647
bevacizumab (625) 625
breast cancer (607) 607
carcinoma (601) 601
cancer therapies (593) 593
kidney neoplasms - pathology (558) 558
disease-free survival (550) 550
endothelial growth-factor (550) 550
patients (549) 549
sunitinib (544) 544
breast-cancer (529) 529
renal cell carcinoma (525) 525
article (524) 524
neoplasms - therapy (522) 522
retrospective studies (521) 521
angiogenesis (520) 520
carcinoma, renal cell - drug therapy (519) 519
review (519) 519
metastases (513) 513
metastatic (509) 509
kidney neoplasms - drug therapy (508) 508
cancer research (499) 499
medicine, research & experimental (492) 492
pathology (492) 492
clinical trials as topic (489) 489
antineoplastic agents - adverse effects (479) 479
urology & nephrology (479) 479
hematology, oncology and palliative medicine (476) 476
neoplasms - immunology (471) 471
antineoplastic agents (465) 465
development and progression (464) 464
interferon-alpha (464) 464
targeted therapy (463) 463
mice (449) 449
antibodies, monoclonal - therapeutic use (444) 444
trial (442) 442
phase-iii trial (438) 438
antimitotic agents (431) 431
antineoplastic combined chemotherapy protocols - adverse effects (430) 430
vascular endothelial growth factor (426) 426
survival analysis (421) 421
expression (412) 412
carcinoma, renal cell (407) 407
phase-ii (407) 407
colorectal cancer (402) 402
neoplasm staging (401) 401
double-blind (398) 398
open-label (397) 397
diagnosis (395) 395
antineoplastic agents - pharmacology (391) 391
cell biology (389) 389
hematology (381) 381
toxicity (377) 377
survival rate (375) 375
dendritic cells (371) 371
solid tumors (368) 368
medical research (367) 367
medicine (366) 366
risk factors (365) 365
angiogenesis inhibitors - therapeutic use (362) 362
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8658) 8658
French (81) 81
Japanese (70) 70
German (65) 65
Russian (46) 46
Polish (17) 17
Spanish (15) 15
Korean (9) 9
Turkish (5) 5
Czech (3) 3
Italian (3) 3
Portuguese (2) 2
Arabic (1) 1
Chinese (1) 1
Hungarian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 704 - 710
Journal Article
Journal Article
Journal Article
Journal Article
Current Drug Targets, ISSN 1389-4501, 06/2016, Volume 17, Issue 7, pp. 771 - 776
Renal cell carcinoma (RCC) is one of the most immunoresponsive human cancers. High-dose IL-2 and Interferon-alpha were once the principle therapies for... 
Metastatic renal cell carcinoma | Immunotherapy | Kidney cancer | Immunotargets | SAFETY | metastatic renal cell carcinoma | COMBINATION | CANCER | kidney cancer | ANTI-PD-L1 ANTIBODY | COMPLETE RESPONSES | PHARMACOLOGY & PHARMACY | B7-H1 | EXPRESSION | PD-1 | immunotargets | LYMPHOCYTES
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 49, pp. 37 - 44
Highlights • The therapeutic landscape of renal cell carcinoma (RCC) has greatly expanded in the last decade. • Clinicians are used to classify RCC based on... 
Hematology, Oncology and Palliative Medicine | Metastatic renal cell carcinoma | TKI | Precision medicine | Non-clear cell renal cell carcinoma | Targeted therapy | mTOR | PD-L1 | Clear cell renal cell carcinoma | Personalized medicine | PD-1 | SURVIVAL | FIBROBLAST-GROWTH-FACTOR | OPEN-LABEL | PHASE-II TRIAL | INTERFERON-ALPHA | IN-VITRO | ONCOLOGY | C-MET | DOUBLE-BLIND | PATIENTS PTS | INHIBITOR | AMP-Activated Protein Kinases - metabolism | Kidney Neoplasms - genetics | Glucose Transporter Type 4 - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Carcinoma, Renal Cell - genetics | Glucose Transporter Type 1 - metabolism | Kidney Neoplasms - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Vascular Endothelial Growth Factor A - metabolism | Molecular Targeted Therapy | Fumarate Hydratase - metabolism | TOR Serine-Threonine Kinases - genetics | Receptors, Fibroblast Growth Factor - genetics | Hepatocyte Growth Factor - genetics | Carcinoma, Renal Cell - drug therapy | Proto-Oncogene Proteins c-akt - metabolism | Precision Medicine | Signal Transduction | Epidermal Growth Factor - metabolism | B7-H1 Antigen - genetics | Hepatocyte Growth Factor - metabolism | Proto-Oncogene Proteins c-met - genetics | Carcinoma, Renal Cell - metabolism | Platelet-Derived Growth Factor - metabolism | Metabolic Networks and Pathways | Succinate Dehydrogenase - metabolism | Mutation | Kidney Neoplasms - drug therapy | Programmed Cell Death 1 Receptor - genetics | Antimitotic agents | Care and treatment | Carcinoma, Renal cell | Antineoplastic agents | Cancer
Journal Article
Journal Article
Journal Article